Helius to Showcase Innovative PoNS Device at ACRM's 2022 - GlobeNewswire

NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) volition showcase its innovative caller Portable Neuromodulation Stimulator (PoNS®) astatine the 99^th yearly American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 successful Chicago. Visitors to booth 512 volition spot the instrumentality and larn much astir however it tin improve gait deficiency successful radical with aggregate sclerosis (MS).

PoNS works by delivering electrical impulses done nervus fibers connected the tongue, stimulating the travel of millions of neural impulses to the encephalon structures that power gait. This creates a cascade of enactment successful the encephalon that – erstwhile combined with an workout regimen supervised by a carnal therapist – produces a neuromodulatory and neuroplastic effect that tin person a important interaction connected the independency and idiosyncratic productivity of radical with MS. (Results of this survey tin beryllium recovered at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017705/)

“The ACRM is committed to helping radical unrecorded their fullest lives by improving, expanding and regaining mobility, and we’re excited to grounds astatine the Conference due to the fact that we stock the aforesaid goals,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer. “PoNS addresses a complication that’s precise top-of-mind for radical with MS: 70% of them study having trouble walking, and of that radical 70% place gait shortage arsenic the astir challenging facet of their disease.”

In summation to seeing the PoNS instrumentality successful person, booth visitors tin talk with cardinal Helius squad members, who tin reply questions astir PoNS and the accompanying PoNS Therapy regimen that maximizes its effectiveness. Physical therapists besides volition beryllium capable to motion up for free, online PoNS Therapy training.

“Rehabilitation professionals who enactment with radical with MS, oregon are funny successful the narration betwixt neuromodulation and gait, are invited to sojourn america astatine booth 512,” said Favit-Van Pelt. “But this is much than conscionable a accidental to spot the instrumentality and talk, it’s an accidental to instrumentality action: By signing up for grooming carnal therapists are making themselves adjacent much invaluable to their patients with MS.”

About Helius Medical Technologies, Inc.
Helius Medical Technologies is simply a starring neurotech institution successful the aesculapian instrumentality tract focused connected neurologic deficits utilizing non-implantable level technologies that amplify the brain’s quality to compensate and beforehand neuroplasticity, improving the lives of radical dealing with neurologic diseases. The Company’s archetypal commercialized merchandise is the Portable Neuromodulation Stimulator (PoNS®). For much information, sojourn www.heliusmedical.com.

About the PoNS Device and PoNS Therapy
The Portable Neuromodulation Stimulator (PoNS) is an innovative non-surgical aesculapian device, inclusive of a controller and mouthpiece, which delivers electrical stimulation to the aboveground of the lingua to amended equilibrium and gait. The PoNS instrumentality is indicated for usage successful the United States arsenic a short-term attraction of gait shortage owed to mild-to-moderate symptoms from aggregate sclerosis (“MS”) and is to beryllium utilized arsenic an adjunct to a supervised therapeutic workout programme successful patients 22 years of property and implicit by medicine only. Helius is advancing PoNS post-approval probe successful MS done a precocious launched Therapeutic Experience Program (TEP) designed to spouse with neurologists and neurorehabilitation therapists astatine 10-12 US centers of excellence, who explicit an involvement successful becoming “early adopters” of PoNS therapy. For much accusation sojourn www.ponstherapy.com.